Furthermore, ivabradine upregulated the expression of miR-133a under Ang II exposure and inhibited Ang II-induced PVF activation, suggesting that ivabradine inhibits cardiac fibroblast activation and ameliorates myocardial fibrosis by upregulating miR-133a expression. The gene discussed is AGT; the disease is Myocardial fibrosis.